SCHEMBL31240485

SCHEMBL31240485

Nc1n[nH]c2ccc(-c3ccnc4[nH]c(-c5cc(N6CCOCC6)nc(N6CCOCC6)c5)cc34)cc12

nearest known ligand 0.54

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ TBK1 Q9UHD2 17/20 0.54
▸ PDPK1 O15530 1/20 0.47
▸ LRRK2 Q5S007 1/20 0.45
▸ JAK2 O60674 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240533 0.93 TBK1 (0.54) TBK1LRRK2
SCHEMBL31240589 0.91 TBK1 (0.60) TBK1
SCHEMBL31240416 0.87 TBK1 (0.44) TBK1LRRK2JAK2
SCHEMBL31240366 0.84 TBK1 (0.52) TBK1LRRK2
SCHEMBL31240473 0.83 DYRK1A (0.51) TBK1PDPK1LRRK2JAK2
SCHEMBL31240247 0.83 JAK2 (0.67) TBK1JAK2
SCHEMBL31240351 0.82 DYRK1A (0.46) TBK1JAK2
SCHEMBL31240700 0.82 CLK2 (0.58) TBK1JAK2
SCHEMBL31240628 0.80 CLK2 (0.55) TBK1JAK2
SCHEMBL31240412 0.79 CLK2 (0.51) JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback